These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 31395362)

  • 1. Reviewing the Demographic, Prognostic, and Treatment Factors of Primary Adenocarcinoma of the Bladder: A SEER Population-based Study.
    Natale C; Leinwand GZ; Chiang J; Silberstein JL; Krane LS
    Clin Genitourin Cancer; 2019 Oct; 17(5):380-388. PubMed ID: 31395362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contemporary rates of pathological features and mortality for adenocarcinoma of the urinary bladder in the USA.
    Zaffuto E; Gazdovich S; Leyh-Bannurah SR; Huland H; Abdollah F; Shariat SF; Menon M; Briganti A; Montorsi F; Karakiewicz PI
    Int J Urol; 2017 Feb; 24(2):117-123. PubMed ID: 27875858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anterior wall adenocarcinoma of bladder with similar clinicopathological and prognostic characteristics as common bladder carcinomas should not be treated as or classified into urachal adenocarcinomas.
    Zhou YW; Long YX; Song K; Liang LB; Cheng K; Chen Y; Liu JY
    Cancer Med; 2021 Aug; 10(16):5415-5428. PubMed ID: 34278741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of tumor location on survival in urinary bladder adenocarcinoma: A population-based analysis.
    Dutta R; Abdelhalim A; Martin JW; Vernez SL; Faltas B; Lotan Y; Youssef RF
    Urol Oncol; 2016 Dec; 34(12):531.e1-531.e6. PubMed ID: 27427223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment Options for Signet Ring Cell Carcinoma of the Urinary Bladder: A Population-Based Study.
    Xie Y; Zhang Y; Du Z; Liu D; Yan W; Liu Y; Ping H
    Cancer Control; 2024; 31():10732748241278485. PubMed ID: 39159955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival in signet ring cell carcinoma varies based on primary tumor location: a Surveillance, Epidemiology, and End Results database analysis.
    Wu SG; Chen XT; Zhang WW; Sun JY; Li FY; He ZY; Pei XQ; Lin Q
    Expert Rev Gastroenterol Hepatol; 2018 Feb; 12(2):209-214. PubMed ID: 29227748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features, treatment, and prognosis of different histological types of primary small bowel adenocarcinoma: A propensity score matching analysis based on the SEER database.
    Zhou YW; Xia RL; Chen YY; Ma XL; Liu JY
    Eur J Surg Oncol; 2021 Aug; 47(8):2108-2118. PubMed ID: 33849741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact of Epidemiological Factors and Treatment Interventions on Survival in Patients With Signet Ring Cell Carcinoma of the Pancreas.
    Patel M; Hans HS; Pan K; Khan H; Donath E; Caldera H
    Am J Clin Oncol; 2018 Dec; 41(12):1176-1184. PubMed ID: 29672365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic implications of signet ring cell histology in esophageal adenocarcinoma.
    Yendamuri S; Huang M; Malhotra U; Warren GW; Bogner PN; Nwogu CE; Groman A; Demmy TL
    Cancer; 2013 Sep; 119(17):3156-61. PubMed ID: 23719932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Variables in Patients With Non-metastatic Small-cell Neuroendocrine Carcinoma of the Bladder: A Population-Based Study.
    Cattrini C; Cerbone L; Rubagotti A; Zinoli L; Latocca MM; Messina C; Zanardi E; Boccardo F
    Clin Genitourin Cancer; 2019 Aug; 17(4):e724-e732. PubMed ID: 31160193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of signet-ring cell carcinoma histology on bladder cancer outcome.
    Wang J; Wang FW; Kessinger A
    World J Urol; 2012 Dec; 30(6):777-83. PubMed ID: 21706144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in survival among patients with urachal and nonurachal adenocarcinomas of the bladder.
    Wright JL; Porter MP; Li CI; Lange PH; Lin DW
    Cancer; 2006 Aug; 107(4):721-8. PubMed ID: 16826584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic value of signet ring cell histology in stage I/II colon cancer-a population-based, propensity score-matched analysis.
    Ackermann CJ; Guller U; Jochum W; Schmied BM; Warschkow R
    Int J Colorectal Dis; 2018 Sep; 33(9):1183-1193. PubMed ID: 29881972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of Korean patients with clinically localized urachal or non-urachal adenocarcinoma of the bladder.
    Cho SY; Moon KC; Park JH; Kwak C; Kim HH; Ku JH
    Urol Oncol; 2013 Jan; 31(1):24-31. PubMed ID: 21458312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A California Cancer Registry Analysis of Urothelial and Non-urothelial Bladder Cancer Subtypes: Epidemiology, Treatment, and Survival.
    Martin JW; Jefferson FA; Huang M; Sung JM; Chang J; Piranviseh K; Ziogas A; Anton-Culver H; Youssef RF
    Clin Genitourin Cancer; 2020 Jun; 18(3):e330-e336. PubMed ID: 32144047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Squamous Cell Carcinoma of the Bladder: A SEER Database Analysis.
    Abdel-Rahman O
    Clin Genitourin Cancer; 2017 Jun; 15(3):e463-e468. PubMed ID: 27876505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics and outcomes of patients with primary signet-ring cell carcinoma of the urinary bladder.
    Wang J; Wang FW
    Urol Int; 2011; 86(4):453-60. PubMed ID: 21525723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Effect of Tumor Sidedness in Colorectal Cancer: A SEER-Based Analysis.
    Li Y; Feng Y; Dai W; Li Q; Cai S; Peng J
    Clin Colorectal Cancer; 2019 Mar; 18(1):e104-e116. PubMed ID: 30448100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 10-year outcomes evaluation of mucinous and signet-ring cell carcinoma of the colon and rectum.
    Kang H; O'Connell JB; Maggard MA; Sack J; Ko CY
    Dis Colon Rectum; 2005 Jun; 48(6):1161-8. PubMed ID: 15868237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic features and utility of immunohistochemical markers in signet-ring cell adenocarcinoma of the bladder.
    Thomas AA; Stephenson AJ; Campbell SC; Jones JS; Hansel DE
    Hum Pathol; 2009 Jan; 40(1):108-16. PubMed ID: 18789486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.